Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T19:50:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:48:05.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:56:25.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previous detailed study record and navigation. This blocks access to the trial information and related resources on that page.
    Difference
    20%
    Check dated 2026-09-20T22:50:07.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's documentation or styling. This change represents an internal version update rather than a substantive alteration to user-facing content.
    Difference
    0.1%
    Check dated 2026-08-30T15:41:54.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.5, indicating a new published revision of the page. This update does not modify the study content or details.
    Difference
    0.1%
    Check dated 2026-08-08T23:27:49.000Z thumbnail image

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.